Login / Signup

Elucidating the Role of Santalol as a Potent Inhibitor of Tyrosinase: In Vitro and In Silico Approaches.

Nabeel AliZainy ZehraAnas ShamsiMd Amjad BegZahoor Ahmad Parraynull IsrailMd Ali ImamNaseem A GaurM D Imtaiyaz HassanAnis Ahmad ChaudharyHassan Ahmed RudayniMohammed Ibrahim AlghonaimSulaiman A AlsalamahAsimul Islam
Published in: Molecules (Basel, Switzerland) (2022)
This research work focuses on the potential application of an organic compound, santalol, obtained from santalum album, in the inhibition of the enzyme tyrosinase, which is actively involved in the biosynthesis of melanin pigment. Over-production of melanin causes undesirable pigmentation in humans as well as other organisms and significantly downgrades their aesthetic value. The study is designed to explain the purification of tyrosinase from the mushroom Agaricus bisporus , followed by activity assays and enzyme kinetics to give insight into the santalol-modulated tyrosinase inhibition in a dose-dependent manner. The multi-spectroscopic techniques such as UV-vis, fluorescence, and isothermal calorimetry are employed to deduce the efficiency of santalol as a potential candidate against tyrosinase enzyme activity. Experimental results are further verified by molecular docking. Santalol, derived from the essential oils of santalum album, has been widely used as a remedy for skin disorders and a potion for a fair complexion since ancient times. Based on enzyme kinetics and biophysical characterization, this is the first scientific evidence where santalol inhibits tyrosinase, and santalol may be employed in the agriculture, food, and cosmetic industries to prevent excess melanin formation or browning.
Keyphrases
  • molecular docking
  • human health
  • climate change
  • high throughput
  • single molecule
  • adipose tissue
  • soft tissue
  • skeletal muscle
  • insulin resistance
  • energy transfer